
Vyluma Inc. will focus on the development and commercialization of therapies to treat ophthalmic diseases, including pediatric myopia.

Vyluma Inc. will focus on the development and commercialization of therapies to treat ophthalmic diseases, including pediatric myopia.

Investigators find increased treatment regimen is effective and long-lasting for patients.


Community involvement, research continue to boost treatment in pediatric population.

Nine pediatric patients with Leber congenital amaurosis show visual improvement in clinical trials.

New paradigm-changing treatments for young patients on the horizon.













Researchers hope questionnaire will lead to a world where patient-reported outcome measures are commonly used in pediatric eye care, not just for research but also in clinical practice.


Group provides update on possible role of computer game rather than patching, eye drops

Microinstrumentation provides surgeons increased control

One pediatric ophthalmologist has spent 30 years educating the Louisiana community’s stakeholders about the importance of vision screening for young children.

Device is noninvasive, nonthreatening; does not require topical or general anesthesia

Level of evidence is decent, but may not be applicable to all racial, ethnic groups